NCT03906370View on ClinicalTrials.gov

Capillary Dysfunction and CD46-immunoreceptor (CD46) Type in MS

CompletedOBSERVATIONAL
Enrollment

83

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

May 1, 2021

Study Completion Date

May 1, 2021

Conditions
Multiple Sclerosis
Interventions
DIAGNOSTIC_TEST

Diagnostic criteria for MS

The diagnosis healthy/diseased was made by 2017 Mc Donald criteria.

Trial Locations (1)

Unknown

Department of Neurology, Aarhus

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT03906370 - Capillary Dysfunction and CD46-immunoreceptor (CD46) Type in MS | Biotech Hunter | Biotech Hunter